CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model

Abstract Background GPRC6A is implicated in the pathogenesis of prostate cancer, but its role remains uncertain because of a purported tolerant gene variant created by substitution of a K..Y polymorphism in the 3rd intracellular loop (IL) that evolved in the majority of humans and replaces the ances...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ruisong Ye, Min Pi, John V. Cox, Satoru K. Nishimoto, L. Darryl Quarles
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMC 2017-06-01
Reeks:Journal of Experimental & Clinical Cancer Research
Onderwerpen:
Osteocalcin
GPRC6A
CRISPR/Cas9
Prostate cancer
Online toegang:http://link.springer.com/article/10.1186/s13046-017-0561-x
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items